170 related articles for article (PubMed ID: 32346368)
1. The MicroRNA MiR-29c Alleviates Renal Fibrosis via TPM1-Mediated Suppression of the Wnt/β-Catenin Pathway.
Huang H; Huang X; Luo S; Zhang H; Hu F; Chen R; Huang C; Su Z
Front Physiol; 2020; 11():331. PubMed ID: 32346368
[TBL] [Abstract][Full Text] [Related]
2. Exosomal miR-21 from tubular cells contributes to renal fibrosis by activating fibroblasts via targeting PTEN in obstructed kidneys.
Zhao S; Li W; Yu W; Rao T; Li H; Ruan Y; Yuan R; Li C; Ning J; Li S; Chen W; Cheng F; Zhou X
Theranostics; 2021; 11(18):8660-8673. PubMed ID: 34522205
[No Abstract] [Full Text] [Related]
3. Sp1 mediates microRNA-29c-regulated type I collagen production in renal tubular epithelial cells.
Jiang L; Zhou Y; Xiong M; Fang L; Wen P; Cao H; Yang J; Dai C; He W
Exp Cell Res; 2013 Aug; 319(14):2254-65. PubMed ID: 23806282
[TBL] [Abstract][Full Text] [Related]
4. miR-29c Inhibits Renal Interstitial Fibrotic Proliferative Properties through PI3K-AKT Pathway.
Feng W; Xie H; Li J; Yan X; Zhu S; Sun S
Appl Bionics Biomech; 2022; 2022():6382323. PubMed ID: 36051820
[TBL] [Abstract][Full Text] [Related]
5. Upregulated miR-29c suppresses silica-induced lung fibrosis through the Wnt/β-catenin pathway in mice.
Wang X; Xu K; Yang XY; Liu J; Zeng Q; Wang FS
Hum Exp Toxicol; 2018 Sep; 37(9):944-952. PubMed ID: 29216763
[TBL] [Abstract][Full Text] [Related]
6. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
7. Astragaloside IV inhibits renal tubulointerstitial fibrosis by blocking TGF-β/Smad signaling pathway in vivo and in vitro.
Wang L; Chi YF; Yuan ZT; Zhou WC; Yin PH; Zhang XM; Peng W; Cai H
Exp Biol Med (Maywood); 2014 Oct; 239(10):1310-24. PubMed ID: 24879422
[TBL] [Abstract][Full Text] [Related]
8. WISP3 prevents fibroblast-myofibroblast transdifferentiation in NRK-49F cells.
Yi Y; Ma J; Jianrao L; Wang H; Zhao Y
Biomed Pharmacother; 2018 Mar; 99():306-312. PubMed ID: 29353205
[TBL] [Abstract][Full Text] [Related]
9. Melatonin ameliorates renal fibroblast-myofibroblast transdifferentiation and renal fibrosis through miR-21-5p regulation.
Li N; Wang Z; Gao F; Lei Y; Li Z
J Cell Mol Med; 2020 May; 24(10):5615-5628. PubMed ID: 32243691
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of spleen tyrosine kinase (syk) suppresses renal fibrosis through anti-inflammatory effects and down regulation of the MAPK-p38 pathway.
Chen KH; Hsu HH; Yang HY; Tian YC; Ko YC; Yang CW; Hung CC
Int J Biochem Cell Biol; 2016 May; 74():135-44. PubMed ID: 26948651
[TBL] [Abstract][Full Text] [Related]
11. Deletion of FHL2 in fibroblasts attenuates fibroblasts activation and kidney fibrosis via restraining TGF-β1-induced Wnt/β-catenin signaling.
Duan Y; Qiu Y; Huang X; Dai C; Yang J; He W
J Mol Med (Berl); 2020 Feb; 98(2):291-307. PubMed ID: 31927599
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-27a targets Sfrp1 to induce renal fibrosis in diabetic nephropathy by activating Wnt/β-Catenin signalling.
Shi M; Tian P; Liu Z; Zhang F; Zhang Y; Qu L; Liu X; Wang Y; Zhou X; Xiao Y; Guo B
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32484208
[TBL] [Abstract][Full Text] [Related]
13. miR-29c is downregulated in renal interstitial fibrosis in humans and rats and restored by HIF-α activation.
Fang Y; Yu X; Liu Y; Kriegel AJ; Heng Y; Xu X; Liang M; Ding X
Am J Physiol Renal Physiol; 2013 May; 304(10):F1274-82. PubMed ID: 23467423
[TBL] [Abstract][Full Text] [Related]
14. FHL2 participates in renal interstitial fibrosis by altering the phenotype of renal tubular epithelial cells via regulating the β-catenin pathway.
Zhou SG; Ma HJ; Guo ZY; Zhang W; Yang X
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2734-2741. PubMed ID: 29771425
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of miR-29c promotes the progression of oral submucous fibrosis through targeting tropomyosin-1.
Yang PY; Ho DC; Chen SH; Hsieh PL; Liao YW; Tsai LL; Yu CC; Fang CY
J Formos Med Assoc; 2022 Jun; 121(6):1117-1122. PubMed ID: 34696938
[TBL] [Abstract][Full Text] [Related]
16. MiR-155-5p promotes renal interstitial fibrosis in obstructive nephropathy via inhibiting SIRT1 signaling pathway.
Wang Z; Chen R; Xu Z; Ru W; Tian H; Yang F; Tao C
J Recept Signal Transduct Res; 2021 Oct; 41(5):466-475. PubMed ID: 32985331
[TBL] [Abstract][Full Text] [Related]
17. Fer exacerbates renal fibrosis and can be targeted by miR-29c-3p.
Sun CM; Zhang WY; Wang SY; Qian G; Pei DL; Zhang GM
Open Med (Wars); 2021; 16(1):1378-1385. PubMed ID: 34595351
[TBL] [Abstract][Full Text] [Related]
18. Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis.
Surendran K; Schiavi S; Hruska KA
J Am Soc Nephrol; 2005 Aug; 16(8):2373-84. PubMed ID: 15944336
[TBL] [Abstract][Full Text] [Related]
19. Poricoic acid A as a modulator of TPH-1 expression inhibits renal fibrosis
Chen DQ; Wu XQ; Chen L; Hu HH; Wang YN; Zhao YY
Ther Adv Chronic Dis; 2020; 11():2040622320962648. PubMed ID: 33062239
[TBL] [Abstract][Full Text] [Related]
20. Silenced miR-21 inhibits renal interstitial fibrosis via targeting ERK1/2 signaling pathway in mice.
Tang CR; Luo SG; Lin X; Wang J; Liu Y
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):110-116. PubMed ID: 31389582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
